Top 3 Capex — 2025

Three companies investing aggressively today whose operating leverage could meaningfully play out over FY26 and beyond.

Top 3 Capex — 2025 — cover image

1) Deepak Fertilizers

Leading Indian chemical and fertiliser producer with three main verticals: Mining (Technical Ammonium Nitrate – TAN), Crop Nutrition (CNB), and Industrial Chemicals (IC).

  • ₹4,500 crore capex programme underway
  • TAN project at Gopalpur: 376 KTPA capacity
  • Nitric Acid project at Dahej: 300 KTPA WNA + 150 KTPA CNA
  • Expected commissioning: H2 FY26

Backward integration benefits: The 5 lakh ton per annum ammonia plant stabilisation provides consistent raw material supply and competitive advantage.

2) HCG

HCG is India's largest pan-India oncology hospital chain dedicated to comprehensive cancer care.

  • 9-month capex: ₹172 crore
  • FY25–FY26 annual capex guidance: ₹275–280 crore per annum
  • Q3 FY25 operational beds: 1,518

KKR acquisition: KKR PE acquired 54% stake with strong healthcare experience and a successful turnaround track record.

3) SRF

SRF Limited manufactures industrial and specialty intermediates across Fluorochemicals, Specialty Chemicals, Packaging Films, Technical Textiles, and Coated and Laminated Fabrics.

  • FY26 capex for current and future projects: ₹1,500–2,000 crore range
  • Specialty chemical projects capitalised over the last 6–7 quarters: approximately ₹2,000 crore

This is not stock advice. Content is for informational and research purposes only.

Recent posts

See all blogs →